Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report.
Shoko SakanoHirofumi MatsuyamaHidehiro IshikawaAkihiro ShindoYuichiro IiKeita MatsuuraMinoru MizutaniNorikazu KawadaHidekazu TomimotoPublished in: BMC neurology (2020)
In patients with MM, the possibility of co-existing of autoimmune disease, including MuSK-MG, should be considered. This case emphasizes the need to still consider testing for anti-MuSK antibodies in older MM patients where there is clinical suspicion for possible MG despite negative anti-acetylcholine receptor antibodies and lacking classic MuSK MG phenotype at onset.